Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Leveraging Artificial Intelligence for the Assessment of Severity of Depressive Symptoms

NCT04370002 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04370002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04370002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Leveraging Artificial Intelligence for the Assessment of Severity of Depressive Symptoms
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 28, 2020
Completion date
November 30, 2024
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

unipolar depression